Literature DB >> 8505282

The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp.

M R Kuhné1, T Pawson, G E Lienhard, G S Feng.   

Abstract

The insulin receptor substrate 1 (IRS1) is a protein that is rapidly phosphorylated on tyrosine by the activated insulin receptor. Syp is a recently discovered, broadly expressed phosphotyrosine (Tyr(P)) phosphatase that contains two Src homology 2 (SH2) domains. We have found that insulin treatment of 3T3-L1 adipocytes leads to complex formation between IRS1 and Syp. Syp was detected in immunoadsorbates of IRS1 from extracts of insulin-treated but not basal cells by both immunoblotting and Tyr(P) phosphatase activity. The association of Syp with IRS1 apparently occurs between the SH2 domains of Syp and Tyr(P)-containing sequences of IRS1, since a fusion protein containing only the SH2 domains of Syp bound the Tyr(P) form of IRS1. Unlike the receptors for epidermal and platelet-derived growth factors, which in their activated state bind to the SH2 domains of Syp and elicit phosphorylation of Syp on tyrosine in intact cells, the Tyr(P) form of the insulin receptor did not bind to the SH2 domains of Syp, and no phosphorylation of Syp on tyrosine was detected in insulin-treated 3T3-L1 adipocytes. In combination with other findings these results indicate that IRS1 functions as a docking protein for SH2 domain-containing proteins participating in signaling from the insulin receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8505282

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  82 in total

1.  Predominant expression of the src homology 2-containing tyrosine phosphatase protein SHP2 in vascular smooth muscle cells.

Authors:  M Adachi; H Iwaki; M Shindoh; Y Akao; T Hachiya; M Ikeda; Y Hinoda; K Imai
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

Review 2.  Targeting protein tyrosine phosphatases for anticancer drug discovery.

Authors:  Latanya M Scott; Harshani R Lawrence; Saïd M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

3.  Annexin II binds to SHP2 and this interaction is regulated by HSP70 levels.

Authors:  Jae Cheal Yoo; Michael J Hayman
Journal:  Biochem Biophys Res Commun       Date:  2007-03-19       Impact factor: 3.575

4.  A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype.

Authors:  S Tanaka; J R Wands
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 5.  The early intracellular signaling pathway for the insulin/insulin-like growth factor receptor family in the mammalian central nervous system.

Authors:  F Folli; S Ghidella; L Bonfanti; C R Kahn; A Merighi
Journal:  Mol Neurobiol       Date:  1996-10       Impact factor: 5.590

Review 6.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

7.  Insulin stimulates the tyrosine dephosphorylation of docking protein p130cas (Crk-associated substrate), promoting the switch of the adaptor protein crk from p130cas to newly phosphorylated insulin receptor substrate-1.

Authors:  A Sorokin; E Reed
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

8.  Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.

Authors:  F Schaper; C Gendo; M Eck; J Schmitz; C Grimm; D Anhuf; I M Kerr; P C Heinrich
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

9.  Roles of insulin, guanosine 5'-[gamma-thio]triphosphate and phorbol 12-myristate 13-acetate in signalling pathways of GLUT4 translocation.

Authors:  M Todaka; H Hayashi; T Imanaka; Y Mitani; S Kamohara; K Kishi; K Tamaoka; F Kanai; M Shichiri; N Morii; S Narumiya; Y Ebina
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

10.  Protein-tyrosine-phosphatase 2C is phosphorylated and inhibited by 44-kDa mitogen-activated protein kinase.

Authors:  P Peraldi; Z Zhao; C Filloux; E H Fischer; E Van Obberghen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.